CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Agios Pharmaceuticals Inc. (AGIO) on Thursday reported a loss of $100.7 million in its second quarter.

The Cambridge, Massachusetts-based company said it had a loss of $1.69 per share.

The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.86 per share.

The biopharmaceutical company posted revenue of $44.7 million in the period, also topping Street forecasts. Three analysts surveyed by Zacks expected $22.7 million.

Agios Pharmaceuticals shares have risen 29% since the beginning of the year. The stock has dropped 7% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AGIO at https://www.zacks.com/ap/AGIO